154 related articles for article (PubMed ID: 34856324)
1. Inquilinus limosus isolated from a patient with chronic cystic fibrosis. First report in Mexico and evidence that co-infection with Pseudomonas aeruginosa promotes the accelerated and increased formation of extracellular neutrophil traps.
Ríos-López AL; Bustamante AE; González GM; Llaca-Diaz JM; Sánchez-González A
Indian J Med Microbiol; 2022; 40(1):156-159. PubMed ID: 34856324
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa isolates from cystic fibrosis patients induce neutrophil extracellular traps with different morphologies that could correlate with their disease severity.
Martínez-Alemán S; Bustamante AE; Jimenez-Valdes RJ; González GM; Sánchez-González A
Int J Med Microbiol; 2020 Oct; 310(7):151451. PubMed ID: 33092695
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection.
Lopes SP; Ceri H; Azevedo NF; Pereira MO
Int J Antimicrob Agents; 2012 Sep; 40(3):260-3. PubMed ID: 22770521
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis.
Martínez-Alemán SR; Campos-García L; Palma-Nicolas JP; Hernández-Bello R; González GM; Sánchez-González A
Front Cell Infect Microbiol; 2017; 7():104. PubMed ID: 28428948
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
[TBL] [Abstract][Full Text] [Related]
6. Intracellular replication of Inquilinus limosus in bronchial epithelial cells.
Lamberti YA; Debandi M; Carrica MDC; Hayes JA; Rodriguez ME
Microb Pathog; 2022 Oct; 171():105742. PubMed ID: 36049652
[TBL] [Abstract][Full Text] [Related]
7. Inquilinus limosus in pulmonary disease: case report and review of the literature.
McHugh KE; Rhoads DD; Wilson DA; Highland KB; Richter SS; Procop GW
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):446-449. PubMed ID: 27717651
[TBL] [Abstract][Full Text] [Related]
8. Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis.
Poore TS; Virella-Lowell I; Guimbellot JS
Pediatr Pulmonol; 2018 Jul; 53(7):E21-E23. PubMed ID: 29790674
[TBL] [Abstract][Full Text] [Related]
9. Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress.
Lopes SP; Azevedo NF; Pereira MO
Int J Med Microbiol; 2017 Dec; 307(8):460-470. PubMed ID: 29033313
[TBL] [Abstract][Full Text] [Related]
10. Draft genome sequence of Inquilinus limosus strain MP06, a multidrug-resistant clinical isolate.
Pino M; Conza JD; Gutkind G
Braz J Microbiol; 2015; 46(4):943-4. PubMed ID: 26691451
[TBL] [Abstract][Full Text] [Related]
11. Continuous infusion meropenem and ticarcillin-clavulanate in pediatric cystic fibrosis patients.
Zobell JT; Ferdinand C; Young DC
Pediatr Pulmonol; 2014 Mar; 49(3):302-6. PubMed ID: 23775821
[TBL] [Abstract][Full Text] [Related]
12. Exopolysaccharides produced by Inquilinus limosus, a new pathogen of cystic fibrosis patients: novel structures with usual components.
Herasimenka Y; Cescutti P; Impallomeni G; Rizzo R
Carbohydr Res; 2007 Nov; 342(16):2404-15. PubMed ID: 17719019
[TBL] [Abstract][Full Text] [Related]
13. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
[TBL] [Abstract][Full Text] [Related]
14. Sustained Coinfections with
Fischer AJ; Singh SB; LaMarche MM; Maakestad LJ; Kienenberger ZE; Peña TA; Stoltz DA; Limoli DH
Am J Respir Crit Care Med; 2021 Feb; 203(3):328-338. PubMed ID: 32750253
[No Abstract] [Full Text] [Related]
15. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
[TBL] [Abstract][Full Text] [Related]
16. DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.
Bhongir RK; Kasetty G; Papareddy P; Mörgelin M; Herwald H; Egesten A
Biochem J; 2017 Feb; 474(3):411-425. PubMed ID: 27784762
[TBL] [Abstract][Full Text] [Related]
17. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Smith S; Waters V; Jahnke N; Ratjen F
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
[TBL] [Abstract][Full Text] [Related]
18. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms of
Biswas L; Götz F
Front Cell Infect Microbiol; 2021; 11():824042. PubMed ID: 35071057
[TBL] [Abstract][Full Text] [Related]
20. Detrimental Effect of Type I IFNs During Acute Lung Infection With
Pylaeva E; Bordbari S; Spyra I; Decker AS; Häussler S; Vybornov V; Lang S; Jablonska J
Front Immunol; 2019; 10():2190. PubMed ID: 31572395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
